- Report
- February 2024
- 85 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Quetiapine is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is a member of the atypical antipsychotic class of drugs, which are used to treat mental illnesses by altering the balance of certain chemicals in the brain. Quetiapine is one of the most commonly prescribed medications in the Central Nervous System (CNS) drug market. It is used to treat a variety of mental health conditions, including schizophrenia, bipolar disorder, and depression. Quetiapine is also used to treat anxiety, insomnia, and other sleep disorders.
Quetiapine is available in both immediate-release and extended-release formulations. The extended-release formulation is designed to provide a steady, consistent level of medication in the body over a longer period of time. Quetiapine is generally well-tolerated, with few side effects. Common side effects include drowsiness, dry mouth, and weight gain.
The quetiapine market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sun Pharmaceuticals, and Dr. Reddy's Laboratories. Show Less Read more